Abstract
Prostate cancer (PC) is the 2nd type most frequently diagnosed malignancy in men, and represents 6% of all causes of death in men worldwide.Despite all medical advances in this area, including the discovery of prostate specific antigen (PSA) for 20 years, are still found many gaps in the diagnosis of PC. PSA is a prostate specific protein but not from PCa and therefore change can be found…